Td Private Client Wealth LLC Moderna, Inc. Transaction History
Td Private Client Wealth LLC
- $3.58 Trillion
- Q4 2024
A detailed history of Td Private Client Wealth LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 37 shares of MRNA stock, worth $914. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37
Previous 339
89.09%
Holding current value
$914
Previous $22.7 Million
93.21%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding MRNA
# of Institutions
925Shares Held
253MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$997 Million0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$961 Million1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$632 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$435 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$181 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $9.67B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...